MHSRS 2024: Day Two Photo Recap

Day two of the Military Health System Research Symposium (MHSRS) in Kissimmee, Florida, continued the spirit of collaboration present at the convention, featuring more presentations from the Uniformed Services University (USU).

Dr. Michael Roy, professor of Medicine at USU’s School of Medicine, spoke about the latest research conclusions from the ongoing INVICTA study during his presentation, “Brain Impact of Subconcussive Blast Exposure During Heavy Weapons Training: the INVestigating training assoCiated blasT pAthology (INVICTA) Study.”
Dr. Michael Roy, professor of Medicine at USU’s School of Medicine, spoke about the latest
research conclusions from the ongoing INVICTA study during his presentation, “Brain Impact
of Subconcussive Blast Exposure During Heavy Weapons Training: the INVestigating training
assoCiated blasT pAthology (INVICTA) Study.”

August 28, 2024 by USU External Affairs

Day two of the Military Health System Research Symposium (MHSRS) in Kissimmee, Florida, featured a series of impactful presentations from the Uniformed Services University (USU). Dr. Michael Roy highlighted the effects of subconcussive blast exposure from the INVICTA study, while Simon Pollett examined how SARS-CoV-2 variants impact vaccine effectiveness. Dr. Xiaoning Jenny Yuan presented advancements in recovery therapies for neuromusculoskeletal injuries, and Maj. Simon Tallowin explored early biomarkers in trauma care. Dr. Ian Stewart discussed novel blood purification methods for treating sepsis. The day exemplified USU’s ongoing efforts to lead in military medical research and innovation.

Dr. (Col.) Ian Stewart, Director, Division of Nephrology, presented results from a study utilizing the Seraph 100 for non-traditional treatments and delivery strategies for wound infections and sepsis. The study was entitled “Blood Purification for the Treatment of Critically Ill Patients with Pathogen Associated Shock: A Multicenter, Randomized Controlled Feasibility Trial (PURIFY-RCT).”
Dr. (Col.) Ian Stewart, director, Division of Nephrology, presented results from a study
utilizing the Seraph 100 for non-traditional treatments and delivery strategies for wound infections
and sepsis. The study was entitled “Blood Purification for the Treatment of Critically Ill Patients
with Pathogen Associated Shock: A Multicenter, Randomized Controlled Feasibility Trial
(PURIFY-RCT).”

Simon Pollett, associate professor of Preventive Medicine and Biostatistics and associate science director, Infectious Diseases Clinical Research Program, presented results from a study entitled “Real-world Evaluation of Vaccine Strain Immune Escape through SARS-CoV-2 Genetic Sieve Analysis: Insights and Future Vaccine Applications.”
Simon Pollett, associate professor of Preventive Medicine and Biostatistics and associate science
director, Infectious Diseases Clinical Research Program, presented results from a study entitled
“Real-world Evaluation of Vaccine Strain Immune Escape through SARS-CoV-2 Genetic Sieve
Analysis: Insights and Future Vaccine Applications.”

Royal Army Medical Corps Maj. (Dr.) Simon Tallowin, a Senior Research Fellow in USU’s Molecular and Cell Biology department presented research on organ support in trauma entitled “Small RNA Sequencing Identifies Early Differential Expression of Whole Blood MicroRNAs in Shocked Trauma Patients.”
Royal Army Medical Corps Maj. (Dr.) Simon Tallowin, a Senior Research Fellow in USU’s
Molecular and Cell Biology department presented research on organ support in trauma entitled
“Small RNA Sequencing Identifies Early Differential Expression of Whole Blood MicroRNAs in
Shocked Trauma Patients.”

Dr. Xiaoning Jenny Yuan, vice chair for Research, Physical Medicine and Rehabilitation
reviewed data collected from utilizing platelet-rich plasma (PRP) injection therapy as a
solution to accelerate recovery from neuromusculoskeletal injury. The research was
entitled “Orthobiologics in Physical Medicine and Rehabilitation: Monitoring Practice
Patterns and Outcomes Using the Military Orthopaedics Tracking Injuries and Outcomes
Network (MOTION).”